Answer
Intravenous dexrazoxane has a reported terminal elimination half-life of 1.9–9.1 hours (median 2.8 hours), while trial TT04 in six female patients treated for anthracycline extravasation found 2.1–2.2 hours throughout days 1–3.
Sources for this answer
- Savene 20 mg/ml powder and solvent for concentrate for solution for infusionCNX Therapeutics Ltd (formerly Sunovion Pharmaceuticals Europe) · emc · SmPC §5.2 Pharmacokinetic properties · Version 1Document updated
Sources checked